U.S. Solon Seeks Answers On FDA Inspection Of Musk's Neuralink

A US lawmaker involved in health policy has queried the Food and Drug Administration (FDA) regarding its failure to inspect Elon Musk's Neuralink before permitting the brain implant company to test its device in humans, according to Marisa Taylor's report for Reuters.

Democratic US Rep. Earl Blumenauer expressed concern that the FDA overlooked "troubling evidence" of animal testing violations dating back to at least 2019. I Image: Neuralink X

Last month, Reuters reported that FDA inspectors discovered issues with record-keeping and quality controls for animal experiments at Neuralink in June, less than a month after the startup claimed clearance to test its brain implants in humans.

Having initially tested its device in monkeys and other animals, Neuralink is now conducting human trials.


The company produces a brain chip enabling paralyzed patients to control a computer using only their thoughts.

In a recent letter to the FDA, Democratic US Rep. Earl Blumenauer expressed concern that the agency overlooked "troubling evidence" of animal testing violations dating back to at least 2019.

Blumenauer also referenced Reuters reports since late 2022, describing employees' complaints of rushed and botched animal experiments causing unnecessary suffering and deaths.

WEEKLY FEATURE : Jose Mari Chan And The Christmas Anthem